BRAND_ANALYSIS#SANOFIHEALTH & PHARMA#21 OF 26 IN HEALTH & PHARMAALIGNED
Sanofi
· Private · Updated 25 May 2026 11:16 UTC
#806 of 1208 overall by tension · #21 of 26 in Health & Pharma
12Aligned
The Balanced
Analysis
Sanofi's 0.50 sentiment reads as pharmaceutical apathy—neither loved nor hated, just pharmaceutically present. C50/B62 positions it as competent infrastructure rather than a brand anyone actively chooses.
IN THE NEWS (58 articles this week)
Sanofi, Wave post updates in race to end AATD’s 40-year drought - Fierce Biotech
Patient Engagement in Healthcare: Listening Beyond the Trial - Sanofi
Sanofi says rare lung disease drug outperforms standard care in trial - Reuters